InterVenn Biosciences Expands Board of Directors with Dr. Jason Myers and Carol Berry to Support Next Phase of Growth

InterVenn Biosciences announced the appointment of Jason Myers, Ph.D., and Carol Berry to the company’s Board of Directors.